Federal Reserve chair says opioid crisis has had ‘quite substantial’ economic impact; GSK hires Genentech veteran to oversee AI; Amazon partners with Britain’s NHS.
Oklahoma case against J&J to continue; Judge strikes down drug price advertising disclosure rule; Novartis steps in with generic EpiPen as shortage continues.
It’s finally here. MM&M delivers the most comprehensive guide to the medical marketing universe.
Agency 100 preview; Canopy Growth fires CEO; Five states to suspend litigation against Insys.
Warren says Gottlieb should quit Pfizer board; Facebook cracks down on outrageous drug claims; Number of drug price increases up 17% over last year.
A healthcare pledge that could come back to haunt Democrats; American Pain Society closes; Bayer backs biotech startup Century Therapeutics.
Harris restates private coverage debate answer; Gottlieb joins Pfizer board; Best strategies for dealing with trolls.
Panel urges millions of hepatitis A vaccinations; Another Apple healthcare move; Google accused of inappropriately accessing medical records.
Omada Health raises $73 million; Key judicial decision on Insys coming next month; Apple Watch, Fitbit integrate Livongo services.
AbbVie to buy Allergan; Judge blocks generics of Novartis’ Gilenya; Illinois becomes 11th state to legalize recreational marijuana.
Trump signs transparency executive order; BMS-Celgene deal to close later than expected; CDC turns to Mutombo to block ebola.
Gottlieb: Juul in a ‘tough spot’ for FDA approval; Trump expected to issue healthcare transparency executive order; Second female libido drug awaits approval.